Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy

Breast Journal

Volumn 14, Issue 2, 2008, Pages 135-140

  Tunon De Lara, Christine ^a   Giard, Sylvia ^b   Buttarelli, Max ^c   Blanchot, Jérome ^d   Classe, Jean Marc ^e   Baron, Marc ^f   Monnier, Brice ^a   Houvenaeghel, Gilles ^c  

^a INSTITUT BERGONIÉ   (France)

^b Oscar Lambret Centre   (France)

^c INSTITUT PAOLI CALMETTES   (France)

^d Eugene Marquis Center   (France)

^e CENTRE RENÉ GAUDUCHEAU   (France)

^f CENTRE HENRI BECQUEREL   (France)

Author keywords

Breast; Ductal carcinoma in situ; Mastectomy; Microinvasive carcinoma; Sentinel node; Underestimation

Indexed keywords

TECHNETIUM;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST DUCT; CANCER GRADING; CANCER INCIDENCE; CARCINOMA IN SITU; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; PARTIAL MASTECTOMY; RISK ASSESSMENT; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; INCIDENCE; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SENTINEL LYMPH NODE BIOPSY;

EID: 40349114275     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2007.00543.x     Document Type: Article

References (34)

1. Cutuli B, Fourquet A, Luporsi E, et al. Standards, options and recommendations for the management of ductal carcinoma in situ of the breast (DCIS): update 2004. Bull Cancer 2005 92 : 155 68.
2. Cox CE, Nguyen K, Gray RJ, et al. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am Surg 2001 67 : 513 9.
3. de Mascarel I, MacGrogan G, Mathoulin-Pelissier S, Soubeyran I, Picot V, Coindre JM. Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas. Cancer 2002 94 : 2134 42.
4. Tunon-de-Lara C, de-Mascarel I, Mac-Grogan G, et al. Analysis of 676 cases of ductal carcinoma in situ of the breast from 1971 to 1995: diagnosis and treatment - the experience of one institute. Am J Clin Oncol 2001 24 : 531 6.
5. Silverstein MJ, Poller DN, Waisman JR, et al. Prognostic classification of breast ductal carcinoma-in-situ. Lancet 1995 345 : 1154 7.
6. Silverstein MJ, Lagios MD, Groshen S, et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 1999 340 : 1455 61.
7. Hermanek P, Hutter R, Sobin L. Union Internationale Contre le Cancer (UICC), Le cancer du sein. Paris : Springer-Verlag, 1998.
8. Tabar L, Tony Chen HH, Amy Yen MF, et al. Mammographic tumor features can predict long-term outcomes reliably in women with 1-14 mm invasive breast carcinoma. Cancer 2004 101 : 1745 59.
9. MacGrogan G, Henriques C, De Mascarel I, et al. Large core of nonpalpable breast lesions. Arch Anat Cytol Pathol 1998 46 : 241 6.
10. Intra M, Veronesi P, Mazzarol G, et al. Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg 2003 138 : 309 13.
11. Lara JF, Young SM, Velilla RE, Santoro EJ, Templeton SF. The relevance of occult axillary micrometastasis in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up. Cancer 2003 98 : 2105 13.
12. Goyal A, Douglas-Jones A, Monypenny I, Sweetland H, Stevens G, Mansel RE. Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ? Analysis of 587 cases. Breast Cancer Res Treat 2006 98 : 314 8.
13. Le Bouedec G, Gimbergues P, Feillel V, Penault-Llorca F, Dauplat J. In situ mammary duct carcinoma with microinvasion. Which axillary lymph node exploration?. Presse Med 2005 34 : 208 12.
14. Adamovich TL, Simmons RM. Ductal carcinoma in situ with microinvasion. Am J Surg 2003 186 : 112 6.
15. Rivadeneira DE, Simmons RM, Christos PJ, Hanna K, Daly JM, Osborne MP. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients. J Am Coll Surg 2000 191 : 1 6 discussion 6 8.
16. Hoorntje LE, Peeters PH, Mali WP, Borel Rinkes IH. Is stereotactic large-core needle biopsy beneficial prior to surgical treatment in BI-RADS 5 lesions? Breast Cancer Res Treat 2004 86 : 165 70.
17. Houssami N, Ciatto S, Ellis I, Ambrogetti D. Underestimation of malignancy of breast core-needle biopsy: concepts and precise overall and category-specific estimates. Cancer 2007 109 : 487 95.
18. Klauber-DeMore N, Tan LK, Liberman L, et al. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion? Ann Surg Oncol 2000 7 : 636 42.
19. Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998 227 : 645 51.
20. Intra M, Zurrida S, Maffini F, et al. Sentinel lymph node metastasis in microinvasive breast cancer. Ann Surg Oncol 2003 10 : 1160 5.
21. Pendas S, Dauway E, Giuliano R, Ku N, Cox CE, Reintgen DS. Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol 2000 7 : 15 20.
22. Kelly TA, Kim JA, Patrick R, Grundfest S, Crowe JP. Axillary lymph node metastases in patients with a final diagnosis of ductal carcinoma in situ. Am J Surg 2003 186 : 368 70.
23. Brady B, Fant J, Jones R, et al. Sentinel lymph node biopsy followed by delayed mastectomy and reconstruction. Am J Surg 2003 185 : 114 7.
24. Fuhrman GM. Sentinel lymph node mapping and biopsy for ductal carcinoma in situ and other controversial indications. Am Surg 2004 70 : 403 6.
25. Weaver DL. Occult 'micrometastases' in ductal carcinoma in situ: investigative implications for sentinel lymph node biopsy. Cancer 2003 98 : 2083 7.
26. Kuerer HM, Newman LA. Lymphatic mapping and sentinel lymph node biopsy for breast cancer: developments and resolving controversies. J Clin Oncol 2005 23 : 1698 705.
27. Yen TW, Hunt KK, Ross MI, et al. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 2005 200 : 516 26.
28. Farkas EA, Stolier AJ, Teng SC, Bolton JS, Fuhrman GM. An argument against routine sentinel node mapping for DCIS. Am Surg 2004 70 : 13 7 discussion 17 8.
29. Zelis JJ, Sickle-Santanello BJ, Liang WC, Nims TA. Do not contemplate invasive surgery for ductal carcinoma in situ. Am J Surg 2002 184 : 348 9.
30. Veronesi P, Intra M, Vento AR, et al. Sentinel lymph node biopsy for localised ductal carcinoma in situ? Breast 2005 14 : 520 2.
31. Klauber-Demore N, Calvo BF, Hultman CS, et al. Staged sentinel lymph node biopsy before mastectomy facilitates surgical planning for breast cancer patients. Am J Surg 2005 190 : 595 7.
32. Trojani M, de Mascarel I, Bonichon F, Coindre JM, Delsol G. Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance. Br J Cancer 1987 55 : 303 6.
33. Chagpar A, Middleton LP, Sahin AA, et al. Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry. Cancer 2005 103 : 1581 6.
34. Houvenaeghel G, Nos C, Mignotte H, et al. Micrometastases in sentinel lymph node in a multicentric study: predictive factors of non-sentinel lymph node involvement - Groupe Des Chirurgiens De La Federation Des Centres De Lutte Contre Le Cancer. J Clin Oncol 2006 24 : 1814 22.